Health
Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion – News-Medical.Net
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as nsp15 and optimized fluorescent biochemical endoribonuclease assays to screen a custom chemical library with over 5,000 commercial compounds. The study is currently available on the bioRxiv* preprint server.
SARS-CoV-2 is a causative agent of coronavirus disease 2019 (COVID-19), a human disease that resulted in millions…
-
General21 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News7 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Noosa News23 hours agoPerth Royal Show attendance slumps to 10-year low
-
Business10 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400